UCB Pharma AB (Sweden)
Olof Palmes gata 29
SE-111 22 Stockholm
Telephone: +46 (0)40-294900

Companies with similar products and services, and with detailed information

Products and services

To view this data requires an Access
Fiscal year 202412
Number of months: 12
Turnover: 264,177
Financial expenses: 1,133
Earnings before taxes: 12,810
Total assets: 166,615
Current assets: 166,615
Current liabilities: 102,704
Equity capital: 63,911
Share capital: 100
Number of employees: 35

Financial ratios

Solvency: 38.4%
Turnover per employee: 7,548
Profitability: 4.8%
Return on equity (ROE): 20.0%
Current ratio: 162.2%
Return on assets (ROA): 8.4%